British Pharmaceutical Conference and Exhibition 2008


SUNDAY - MONDAY - TUESDAY

am Sunday 7 SEPTEMBER
11.45 – 12.30 COFFEE and TEA, including official opening of the exhibition. Lunch will be on sale from 12.00 - 14.30

THE SCIENCE OF PHARMACY	SCIENCE INTO PRACTICE	THE PRACTICE OF PHARMACY

	11.00 - 11.10 President’s welcome The President, Royal Pharmaceutical Society of Great Britain

	11.10 - 11.45 Keynote address
	Keynote address In the chair: President, Royal Pharmaceutical Society of Great Britain
	Pharmacy in the 21st Century: Life to Years and Years to Life ;The contribution of Pharmaceutical Science and Pharmacists Prof Trevor M Jones CBE, Allergan Inc	12.00 - 13.30 A choice of:
	Sponsored by	The future pharmacy regulatory and professional bodies: latest developments
		In the Chair: Olivia Timbs, Editor, The Pharmaceutical Journal
12.30 - 14.30 A choice of:	12.30 – 14.30 Cancer medicine	The professional body Nigel Clarke, Chairman, The Clarke Inquiry
Nano-engineering: novel approaches to rapid diagnostic systems	In the chair: Deborah Ladenheim, Avidimer Therapeutics Inc	The regulatory body Ken Jarrold, Chairman, PRLOG
In association with the American Academy of Pharmaceutical Sciences		The view from the Society
In the chair: Patrick Sinko, Rutgers University, USA	Chemoprevention for cancer: to take or not to take? Liam Murray, Queen’s University, Belfast	Jeremy Holmes, Chief Executive and Registrar, Royal Pharmaceutical Society of Great Britain

Microfluidic technologies and platforms enabling rapid diagnostics Giles Sanders, The Thomas Group	Pharmaceutical care of patients with cancer Geoff Saunders, Manchester and Cheshire Cancer Network	Or
		Polypharmacy: too much or too little? In the chair: Carmel Hughes, BPC 2008 Practice Chair
Anisotropic DNA dendrimers as nanobarcodes for rapid disease diagnosis Dan Luo, Cornell University, USA	Exploiting the dark side of anti-hormonal action in breast cancer Julia Gee, University of Cardiff	Polypharmacy: appropriate and inappropriate Jeff Aronson, University of Oxford
		Poly-support for patients with polypharmacy Theo Raynor, University of Leeds
Multifunctional nanoparticles for imaging, delivery, and targeting for diagnosis and drug delivery monitoring Robert Prud’homme, Princeton University, USA	Drug delivery – are we getting there? Chris Twelves, University of Bradford	Rational polypharmacy: the patient's contribution Martin Underwood, University of Warwick

Commercialisation of nanotechnology-based diagnostics and screening tools Steffi Friedrichs, Nanotechnology Industries Association, USA		Or
		Co-operation and collaboration
		Presented by: Gordon Farquhar, The Co-operative Pharmacy
		Sponsored by
Or		Or
Short papers in pharmaceutics In the chair: Julie Cahill, AstraZeneca For further information click here.		12.00 - 14.00
Or		Thriving in the service era: a workshop and advice surgery for community pharmacists
Material sciences		In the chair: John Turk, National Pharmacy Association
In association with the Academy of Pharmaceutical Sciences Focus Group		Sponsored by
In the chair: Brian Stockton, GlaxoSmithKline and Gavin Andrews, Queen’s University, Belfast		Topics to include:
The application of quality by design to excipient supplies: a customer perspective Anthony Taylor, GlaxoSmithKline		Preparing for the challenges of the Pharmacy in England: Building on strengths - delivering the future White Paper
		Taking up ‘new’ clinical services
Functionality-related characteristics of excipients in formulations		Balancing your NHS income streams
Niklas Sandler, AstraZeneca		Embedding quality – including MURs
		The long haul – nurturing key local relationships
Characterisation of excipients for inhalation products Rob Price, University of Bath
		Or
Excipient powders: characterisation of mechanical propertus		12.30 - 14.30
Craig Bentham, Pfizer		From condoms to coronary heart disease: community pharmacy supporting public health
		Selected papers in pharmacy practice research

Or		13.30 - 14.30
		Fringe session
Short papers in pharmacognosy and pharmaceutical chemistry		Sponsored by
In the chair: Sabbir Ahmed, University of Kingston		The National Clinical Assessment Service (NCAS): helping resolve performance concerns
For further information click here.		NCAS provides confidential advice and support to healthcare organisations where the performance of doctors and dentists gives cause for concern. The NCAS will be engaging further with the pharmaceutical profession with the aim to provide a similar service to pharmacists from 2009.
		This session will discuss the issues that arise from this development.
LUNCH WILL BE ON SALE FROM 12.00 – 14.30

pm Sunday 7 SEPTEMBER
11.45 – 12.30 COFFEE and TEA, including official opening of the exhibition. Lunch will be on sale from 12.00 – 14.30

THE SCIENCE OF PHARMACY	SCIENCE INTO PRACTICE	THE PRACTICE OF PHARMACY

		14.30 - 16.00 A choice of:
		Responsible pharmacists: latest news and what it means for the profession and patients
		In the chair: David Pruce, Royal Pharmaceutical Society of Great Britain

		Professional and patient issues Priya Sejpal, Royal Pharmaceutical Society of Great Britain

		The view from the company chemists Rob Darracott, Company Chemists’ Association

15.00 - 17.00 A choice of:	15.00 - 17.00 Cystic fibrosis: scientific developments and their delivery in practice	What it means to the individual pharmacist/patient relationship Mark Koziol, Pharmacists’ Defence Association
Short papers in pharmaceutical analysis	In the chair: Gary Martin, King's College London
In association with the Joint Pharmaceutical Analysis Group		Or
In the chair: Tony Moffat, School of Pharmacy, University of London	Gene therapy for cystic fibrosis Eric Alton, Imperial College
For further information click here.		Quality of care in care homes for older people
Or	Lung infections in cystic fibrosis: challenges in microbial science and patient care John Govan, University of Edinburgh	In the chair: Carmel Hughes, BPC 2008 Practice Chair
Pharmacogenetics: from laboratory to the clinic
In the chair: Munir Pirmohammed, University of Liverpool		What is it about this place? Medication use in residential care Ngaire Kerse, University of Auckland, New Zealand
	Delivering quality care in cystic fibrosis: the importance of a multi-disciplinary team Stuart Elborn, Belfast Health and Social Care Trust
Tamoxifen pharmacogenetics: implications for breast cancer treatment Hiltrud Brauch, Institute of Clinical Pharmacology, Stuttgart, Denmark		Models of care to reduce adverse drug events in nursing homes: what can be done and what to expect Kate Lapane, Brown University, USA

Warfarin pharmacogenetics: ready for clinical implementation Andrea Jorgensen, University of Liverpool	Keeping the patient centre stage Rosie Barnes, Cystic Fibrosis Trust	Medication errors in care homes: what, how, why? Experience from the Care Homes Use of Medicines Study (CHUMS) David Alldred, University of Leeds
Pharmacogenetics: a regulatory perspective Rafe Suvarna, Medicines and Healthcare products Regulatory Agency
		Or
Pharmacogenetics of cancer: current progress challenges and opportunities Romano Danesi, University of Pisa, Italy
		The Co-operative: ethics and sustainability
Or		Presented by: Paul Monaghan, Head of Ethics and Sustainable Development, The Co-operative Pharmacy
Process engineering and formulation design		Sponsored by
In association with the Academy of Pharmaceutical Sciences Focus Group		Or
In the chair: Ron Roberts, AstraZeneca and Kendall Pitt, GlaxoSmithKline
		Best of the best
Building API variability into a design space strategy Stephen McGhie, GlaxoSmithKline		In association with the Company Chemists' Association
		Sponsored by
Quality formulation design – application of the principle of QbD to formulation design Steven Brown, Wyeth		This session will showcase and celebrate a number of examples of pharmacists who are leading the development of professional practice.
Manufacturing process selection for solid oral dosage forms Walter Cook, Pfizer		This interactive session is a chance to learn from their experience, be inspired by their achievements and to share and understand what their work means for them as professionals.

Using process control to ensure operation within design space Gavin Reynolds, AstraZeneca		16.30 - 17.15 Keynote address
		In the chair: Peter Noyce, University of Manchester
Or		Making patient care a reality worldwide Linda Strand, University of Minnesota, USA
Short papers in drug delivery
In the chair : Martin Snowden, University of Greenwich		17.15 - 18.00 Practice posters
For further information click here.
17.15 - 18.00 Harrison Memorial Lecture		15.00 - 17.00 Contracting, commissioning and pharmacy futures
In the Chair: President, Royal Pharmaceutical Society of Great Britain		Selected papers in pharmacy practice research
Patrick Humphrey, Consultant
		15.30 - 17.30
18.00 - 19.00		Adding years to your life: recognising and dealing with occupational stress
Attended science poster session Incorporating wine reception and poster prize presentation supported by the Academy of Pharmaceutical Sciences		Sponsored by
		Topics to include:
		Why is addressing work-related stress important?
		Causes of work-related stress in pharmacy
		Strategies for reducing work related stress

LUNCH WILL BE ON SALE FROM 12.00 – 14.30. 15.30 SNACKS ON SALE. 16.00 – 17.00 REFRESHMENTS ON SALE 20.00 CONFERENCE DINNER. After-dinner entertainment from String Fever followed by dancing to the Right Stuff

Top of page ↑

SUNDAY - MONDAY - TUESDAY

home - theme - call for papers - programme highlights - full programme - booking - press releases - awards - careers forum - social events